Australia markets close in 1 hour 45 minutes

Zhejiang Huakang Pharmaceutical Co., Ltd. (605077.SS)

Shanghai - Shanghai Delayed price. Currency in CNY
Add to watchlist
21.17+0.30 (+1.44%)
At close: 03:00PM CST
Currency in CNY

Valuation measures4

Market cap (intra-day) 4.97B
Enterprise value 5.58B
Trailing P/E 13.93
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)1.85
Price/book (mrq)1.56
Enterprise value/revenue 2.02
Enterprise value/EBITDA 12.48

Trading information

Stock price history

Beta (5Y monthly) N/A
52-week change 3-19.01%
S&P500 52-week change 321.33%
52-week high 328.07
52-week low 315.57
50-day moving average 319.95
200-day moving average 322.57

Share statistics

Avg vol (3-month) 31.39M
Avg vol (10-day) 32.35M
Shares outstanding 5234.61M
Implied shares outstanding 6234.61M
Float 8108.78M
% held by insiders 155.26%
% held by institutions 12.11%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 40.6
Forward annual dividend yield 42.92%
Trailing annual dividend rate 30.70
Trailing annual dividend yield 33.35%
5-year average dividend yield 4N/A
Payout ratio 439.47%
Dividend date 3N/A
Ex-dividend date 428 Apr 2023
Last split factor 21.4:1
Last split date 326 May 2022

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Mar 2024

Profitability

Profit margin 13.06%
Operating margin (ttm)13.03%

Management effectiveness

Return on assets (ttm)4.53%
Return on equity (ttm)12.19%

Income statement

Revenue (ttm)2.77B
Revenue per share (ttm)12.14
Quarterly revenue growth (yoy)-2.40%
Gross profit (ttm)N/A
EBITDA 577.72M
Net income avi to common (ttm)361.42M
Diluted EPS (ttm)1.52
Quarterly earnings growth (yoy)-11.10%

Balance sheet

Total cash (mrq)1.72B
Total cash per share (mrq)7.51
Total debt (mrq)2.33B
Total debt/equity (mrq)73.10%
Current ratio (mrq)3.63
Book value per share (mrq)13.91

Cash flow statement

Operating cash flow (ttm)416.06M
Levered free cash flow (ttm)-875.75M